http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2147747-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72e2a023c558b51d973e979033b70490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716283b4d47c7564eba0b73a2e3c1704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_071d176df181dc0c97436d7c7cfebffd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6680cd1c8b8c228d559000e0b85e9f21
publicationDate 2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2147747-C1
titleOfInvention Method for determining indications to administer antiproteolytic activity preparations in acute period of inflammatory and destructive cornea diseases
abstract FIELD: medicine. SUBSTANCE: method involves applying gelatin as enzyme reaction substratum being a component in photographic emulsion on exposed or developed X-ray film. Trypsin and tears mixture is added (at a dilution of 1: 20). The result is visually evaluated in semi-quantitative way based on lysis zone. Trypsin and tears concentration is selected to retain linear relationship between enzyme activity and antiproteolytic activity of tears. Antiproteolytic activity of tears is expressed in inhibition units determined from calibration curve built with aprotinine used as standard trypsin inhibitor. Antiproteolytic activity being equal to 2.5 inhibition units/ml and lower, protease inhibitor preparations are considered to be indicated. EFFECT: simplified method. 3 dwg
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2634293-C1
priorityDate 1998-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62757
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16613
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397853
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C8A4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP62756
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56538
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81902
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11012
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP82109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y0A1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29993
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600743
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID65223
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664

Total number of triples: 49.